title: In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.
abstract: A characteristic feature of neoplastic transformation is a perpetual activation of oncogenic proteins. Here, we studied signal transducers and activators of transcription (STAT) in patients with mycosis fungoides (MF)/cutaneous T-cell lymphoma (CTCL). Malignant lymphocytes in dermal infiltrates of CTCL tumors showed frequent and intense nuclear staining with anti-PY-STAT3 antibody, indicating a constitutive activation of STAT3 in vivo in tumor stages. In contrast, only sporadic and faint staining was observed in indolent lesions of patch and plaque stages of MF. Moreover, neoplastic lymphocytes in the epidermal Pautrier abscesses associated with early stages of MF did not express activated STAT3. To address the role of STAT3 in survival/apoptosis, CTCL tumor cells from an advanced skin tumor were transfected with either wild-type STAT3 (STAT3wt) or dominant-negative STAT3 (STAT3D). Forced inducible expression of STAT3D triggered a significant increase in tumor cells undergoing apoptosis, whereas forced expression of STAT3wt or empty vector had no effect. In conclusion, a profound in vivo activation of STAT3 is observed in MF tumors but not in the early stages of MF. Moreover, STAT3 protects tumor cells from apoptosis in vitro. Taken together, these findings suggest that STAT3 is a malignancy factor in CTCL.
authors.affiliation: Institutes of Medical Microbiology and Immunology, University of Copenhagen, Copenhagen, Denmark.
authors.forename: V H
authors.initials: VH
authors.lastname: Sommer
authors.forename: O J
authors.initials: OJ
authors.lastname: Clemmensen
authors.forename: O
authors.initials: O
authors.lastname: Nielsen
authors.forename: M
authors.initials: M
authors.lastname: Wasik
authors.forename: P
authors.initials: P
authors.lastname: Lovato
authors.forename: C
authors.initials: C
authors.lastname: Brender
authors.forename: K W
authors.initials: KW
authors.lastname: Eriksen
authors.forename: A
authors.initials: A
authors.lastname: Woetmann
authors.forename: C G
authors.initials: CG
authors.lastname: Kaestel
authors.forename: M H
authors.initials: MH
authors.lastname: Nissen
authors.forename: C
authors.initials: C
authors.lastname: Ropke
authors.forename: S
authors.initials: S
authors.lastname: Skov
authors.forename: N
authors.initials: N
authors.lastname: Ødum
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017209:Apoptosis; D004268:DNA-Binding Proteins / Q000032:analysis / Q000378:metabolism* / Q000502:physiology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008214:Lymphocytes / Q000737:chemistry / Q000473:pathology; D016410:Lymphoma, T-Cell, Cutaneous / Q000737:chemistry* / Q000209:etiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000737:chemistry / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000473:pathology; D009363:Neoplasm Proteins / Q000032:analysis / Q000378:metabolism / Q000502:physiology; D050796:STAT3 Transcription Factor; D012878:Skin Neoplasms / Q000737:chemistry / Q000473:pathology; D015534:Trans-Activators / Q000032:analysis / Q000378:metabolism* / Q000502:physiology
chemical_list: D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D015534:Trans-Activators